Imatinib Unknown Status Phase 2 Trials for Acute Lymphocytic Leukemia (ALL)

IndicationsStatusPurposePhase
Unknown StatusNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00149136Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.